6-hydroxychlorzoxazone has been researched along with Daytime Sleepiness in 1 studies
6-hydroxychlorzoxazone: chlorzoxazone metabolite in humans
Excerpt | Relevance | Reference |
---|---|---|
"Lasofoxifene was tested in 18 postmenopausal women with probe drugs for CYP2E1 and CYP2D6." | 2.72 | Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism. ( Fisher, JM; Gardner, MJ; Kolluri, S; Moller, RA; Obach, RS; Taylor, AE; Walsky, RL, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moller, RA | 1 |
Fisher, JM | 1 |
Taylor, AE | 1 |
Kolluri, S | 1 |
Gardner, MJ | 1 |
Obach, RS | 1 |
Walsky, RL | 1 |
1 trial available for 6-hydroxychlorzoxazone and Daytime Sleepiness
Article | Year |
---|---|
Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism.
Topics: Administration, Oral; Chlorzoxazone; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cy | 2006 |